Cannabidiol as a Prophylactic Agent Against Glioblastoma Growth: A Preclinical Investigation (2026)

Glioblastoma (GBM) remains one of the most lethal brain tumors, with current therapies offering limited benefits and high relapse rates. This study presents the first preclinical evidence that pretreatment with inhaled cannabidiol (CBD) before tumor establishment can markedly inhibit GBM progression